Lucius Dabrafenib – Buy Online
Dabrafenib is a BRAF inhibitor that specifically blocks the activity of BRAF protein, thereby inhibiting the proliferation and survival of tumor cells.
View Product
Essai d’escalade de dose de l’association dabrafenib, tramétinib et AT13387 chez des patients atteints de tumeurs solides mutées BRAF – Wiley & Sons
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF -mutant solid tumors Wiley & Sons
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Products Mentioned in This Article
These products were automatically matched from the article title, summary, and full content.
DABRADX Dabrafenib 75mg
Dabrafenib is a BRAF inhibitor cancer drug, available as a mesylate. On May 29, 2013, the U.S. Food and Drug Administration (FDA) simultaneously approved the marketing applications of dabrafenib and trametinib. Dabrafenib is approved for the treatment of unresectable melanoma (tumors that cannot be surgically removed) and metastatic melanoma (tumors that have spread to other organs) harboring the BRAF V6 Chemicalbook00E mutation, but not for the treatment of wild-type BRAF melanoma. Mekinist is used to treat BRAF V600E or V600...
View Product
Frequently Asked Questions
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Dabrafenib – Buy Online、DABRADX Dabrafenib 75mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
